Front Row Advisors LLC Viatris Inc Transaction History
Front Row Advisors LLC
- $282 Million
- Q2 2024
A detailed history of Front Row Advisors LLC transactions in Viatris Inc stock. As of the latest transaction made, Front Row Advisors LLC holds 891 shares of VTRS stock, worth $10,469. This represents 0.0% of its overall portfolio holdings.
Number of Shares
891
Previous 891
-0.0%
Holding current value
$10,469
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding VTRS
# of Institutions
1,085Shares Held
970MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.65 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.09 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$730 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$676 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$668 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $14.2B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...